Management team

FERNÁNDEZ CHACÓN, RAFAEL Dirección

PÉREZ SIMÓN, JOSÉ ANTONIO Vicedirección

CAÑON CAMPOS, JOSE Gerencia

Headquarters

AVDA. MANUEL SIUROT S/N CAMPUS DEL HOSPITAL UNIVERSITARIO VIRGEN DEL ROCIO
Sevilla (Sevilla)
Spain,
95 592 30 00
http://www.ibis-sevilla.es

Research groups

Ongoing projects

Knowledge transference

A total of 11 Research groups belong to this institute

Grupo

Subárea

CELLULAR NEUROBIOLOGY AND BIOPHYSICS
Endocrine diseases
iNMUNOVIROLOGY
Mechanisms of neuronal maintenance
Microenvironmental physiopathology
Molecular Biology of cancer
MOLECULAR PHYSIOLOGY OF THE SYNAPSE
MOVEMENT DISORDERS
PERINATAL-IBiS LAB
Redox Homeostasis

A total of 18 Ongoing projects belong to this institute

Aggrepoptosis: Ferroptotic cell death induced by protein aggregation
BLOOD-BRAIN BARRIER DISRUPTION BY NON-PRODUCTIVE ANGIOGENESIS IN ALZHEIMER¿S DISEASE
CHARACTERIZATION OF PROGRESSIVE VESSEL LOSS BY NON-PRODUCTIVE ANGIOGENESIS, A NEW PATHOLOGIC MECHANISM IN ALZHEIMER¿S DISEASE?
Characterization of the local vascular component in Alzheimer¿s disease, an update of the gamma-secretase loss of function hypothesis
EXPLORING NOVEL ROLES OF GLUTATHIONE IN PROTEOSTASIS MAINTENANCE
HIF-2A AND PYRUVATE CARBOXYLASE IN PANCREATIC BETA-CELL FORMATION AND FUNCTION
IN-DEEP STUDY OF 3 DIFFERENT BIOLOGICAL PATHWAYS LEADING TO STEMNESS, CELL DEDIFFERENTIATION AND CANCER RESISTANCE
LIVER MITOCHONDRIAL COMPLEX II: IMPACT ON LIVER PATHOPHYSIOLOGY AND METABOLISM. LOOKING FOR THERAPEUTIC OPPORTUNITIES
MECHANISMS OF DE-DIFFERENTIATION TO CANCER STEM CELLS AND RESISTANCE TO CANCER THERAPY
Microglial carbohydrate metabolism in health and disease

A total of 13 investigators belong to this institute

ALBERTO PASCUAL BRAVO
AMALIA MARTINEZ MIR
AMANCIO CARNERO MOYA
ANTONIO MIRANDA VIZUETE
DAVID ANTONIO CANO GONZALEZ
DIEGO GARCIA GONZALEZ
EZEQUIEL RUIZ-MATEOS CARMONA
JAVIER SANCHEZ CESPEDES
MATILDE BUSTOS DE ABAJO
MAURIZIO RIGA

A total of 29 Knowledge transference belong to this institute

BIOMARCADORES DE PRONOSTICO DE SUPERVIVENCIA DESPUES DE TRATAMIENTO DE UNA ENFERMEDAD CANCEROSA CON RADIOTERAPIA YO QUIMIOTERAPIA
BIOMARCADORES DE PRONOSTICO DE SUPERVIVENCIA DESPUES DE TRATAMIENTO DE UNA ENFERMEDAD CANCEROSA CON RADIOTERAPIA YO QUIMIOTERAPIA
CEPAS DE MYCOBACTERIUM HIPERMUTABLES
CEPAS DE PROCARIOTAS GENETICAMENTE HIPERVARIABLES
COMBINACION DE FARMACOS ANTIEGFR Y ANTIFGFR PARA USO EN EL TRATAMIENTO DE TUMORES DE PULMON
COMBINACION DE FARMACOS ANTIEGFR Y ANTIFGFR PARA USO EN EL TRATAMIENTO DE TUMORES DE PULMON
EXPRESSION SIGNATURE FOR GLIOMA DIAGNOSIS ANDOR PROGNOSIS IN A SUBJECT
HYPERMUTABLE ACTINOBACTERIA STRAINS
INHIBIDORES DE FGFR PARA USO EN EL TRATAMIENTO DEL CANCER DE PULMON
INHIBIDORES DE FGFR PARA USO EN EL TRATAMIENTO DEL CANCER DE PULMON

There are no services related to this institute

No se han encontrado resultados para los filtros aplicados